Global AI in Respiratory Diseases Market Insights, Forecast to 2029

TABLE OF CONTENTS

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global AI in Respiratory Diseases Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
  • 1.2.2 Pulmonary Infection
  • 1.2.3 MRI
  • 1.2.4 CT Scan
• 1.3 Market by Application
  • 1.3.1 Global AI in Respiratory Diseases Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
  • 1.3.2 Hospital
  • 1.3.3 Diagnostic Centers
  • 1.3.4 Ambulatory Surgical Centers
  • 1.3.5 Others
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global AI in Respiratory Diseases Market Perspective (2018-2029)
• 2.2 Global AI in Respiratory Diseases Growth Trends by Region
  • 2.2.1 AI in Respiratory Diseases Market Size by Region: 2018 VS 2022 VS 2029
  • 2.2.2 AI in Respiratory Diseases Historic Market Size by Region (2018-2023)
  • 2.2.3 AI in Respiratory Diseases Forecasted Market Size by Region (2024-2029)
• 2.3 AI in Respiratory Diseases Market Dynamics
  • 2.3.1 AI in Respiratory Diseases Industry Trends
  • 2.3.2 AI in Respiratory Diseases Market Drivers
  • 2.3.3 AI in Respiratory Diseases Market Challenges
  • 2.3.4 AI in Respiratory Diseases Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Revenue AI in Respiratory Diseases by Players
  • 3.1.1 Global AI in Respiratory Diseases Revenue by Players (2018-2023)
  • 3.1.2 Global AI in Respiratory Diseases Revenue Market Share by Players (2018-2023)
• 3.2 Global AI in Respiratory Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Global Key Players of AI in Respiratory Diseases, Ranking by Revenue, 2021 VS 2022 VS 2023
• 3.4 Global AI in Respiratory Diseases Market Concentration Ratio
  • 3.4.1 Global AI in Respiratory Diseases Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by AI in Respiratory Diseases Revenue in 2022
• 3.5 Global Key Players of AI in Respiratory Diseases Head office and Area Served
• 3.6 Global Key Players of AI in Respiratory Diseases, Product and Application
• 3.7 Global Key Players of AI in Respiratory Diseases, Date of Enter into This Industry
• 3.8 Mergers & Acquisitions, Expansion Plans

4 AI in Respiratory Diseases Breakdown Data by Type

• 4.1 Global AI in Respiratory Diseases Historic Market Size by Type (2018-2023)
• 4.2 Global AI in Respiratory Diseases Forecasted Market Size by Type (2024-2029)

5 AI in Respiratory Diseases Breakdown Data by Application

• 5.1 Global AI in Respiratory Diseases Historic Market Size by Application (2018-2023)
• 5.2 Global AI in Respiratory Diseases Forecasted Market Size by Application (2024-2029)

6 North America

• 6.1 North America AI in Respiratory Diseases Market Size (2018-2029)
• 6.2 North America AI in Respiratory Diseases Market Size by Type
  • 6.2.1 North America AI in Respiratory Diseases Market Size by Type (2018-2023)
  • 6.2.2 North America AI in Respiratory Diseases Market Size by Type (2024-2029)
  • 6.2.3 North America AI in Respiratory Diseases Market Share by Type (2018-2029)
• 6.3 North America AI in Respiratory Diseases Market Size by Application
  • 6.3.1 North America AI in Respiratory Diseases Market Size by Application (2018-2023)
  • 6.3.2 North America AI in Respiratory Diseases Market Size by Application (2024-2029)
  • 6.3.3 North America AI in Respiratory Diseases Market Share by Application (2018-2029)
• 6.4 North America AI in Respiratory Diseases Market Size by Country
  • 6.4.1 North America AI in Respiratory Diseases Market Size by Country: 2018 VS 2022 VS 2029
  • 6.4.2 North America AI in Respiratory Diseases Market Size by Country (2018-2023)
  • 6.4.3 North America AI in Respiratory Diseases Market Size by Country (2024-2029)
  • 6.4.4 United States
  • 6.4.5 Canada

7 Europe

• 7.1 Europe AI in Respiratory Diseases Market Size (2018-2029)
• 7.2 Europe AI in Respiratory Diseases Market Size by Type
  • 7.2.1 Europe AI in Respiratory Diseases Market Size by Type (2018-2023)
  • 7.2.2 Europe AI in Respiratory Diseases Market Size by Type (2024-2029)
  • 7.2.3 Europe AI in Respiratory Diseases Market Share by Type (2018-2029)
• 7.3 Europe AI in Respiratory Diseases Market Size by Application
  • 7.3.1 Europe AI in Respiratory Diseases Market Size by Application (2018-2023)
  • 7.3.2 Europe AI in Respiratory Diseases Market Size by Application (2024-2029)
  • 7.3.3 Europe AI in Respiratory Diseases Market Share by Application (2018-2029)
• 7.4 Europe AI in Respiratory Diseases Market Size by Country
  • 7.4.1 Europe AI in Respiratory Diseases Market Size by Country: 2018 VS 2022 VS 2029
  • 7.4.2 Europe AI in Respiratory Diseases Market Size by Country (2018-2023)
  • 7.4.3 Europe AI in Respiratory Diseases Market Size by Country (2024-2029)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 China

• 8.1 China AI in Respiratory Diseases Market Size (2018-2029)
• 8.2 China AI in Respiratory Diseases Market Size by Type
  • 8.2.1 China AI in Respiratory Diseases Market Size by Type (2018-2023)
  • 8.2.2 China AI in Respiratory Diseases Market Size by Type (2024-2029)
  • 8.2.3 China AI in Respiratory Diseases Market Share by Type (2018-2029)
• 8.3 China AI in Respiratory Diseases Market Size by Application
  • 8.3.1 China AI in Respiratory Diseases Market Size by Application (2018-2023)
  • 8.3.2 China AI in Respiratory Diseases Market Size by Application (2024-2029)
  • 8.3.3 China AI in Respiratory Diseases Market Share by Application (2018-2029)

9 Asia (excluding China)

• 9.1 Asia AI in Respiratory Diseases Market Size (2018-2029)
• 9.2 Asia AI in Respiratory Diseases Market Size by Type
  • 9.2.1 Asia AI in Respiratory Diseases Market Size by Type (2018-2023)
  • 9.2.2 Asia AI in Respiratory Diseases Market Size by Type (2024-2029)
  • 9.2.3 Asia AI in Respiratory Diseases Market Share by Type (2018-2029)
• 9.3 Asia AI in Respiratory Diseases Market Size by Application
  • 9.3.1 Asia AI in Respiratory Diseases Market Size by Application (2018-2023)
  • 9.3.2 Asia AI in Respiratory Diseases Market Size by Application (2024-2029)
  • 9.3.3 Asia AI in Respiratory Diseases Market Share by Application (2018-2029)
• 9.4 Asia AI in Respiratory Diseases Market Size by Region
  • 9.4.1 Asia AI in Respiratory Diseases Market Size by Region: 2018 VS 2022 VS 2029
  • 9.4.2 Asia AI in Respiratory Diseases Market Size by Region (2018-2023)
  • 9.4.3 Asia AI in Respiratory Diseases Market Size by Region (2024-2029)
  • 9.4.4 Japan
  • 9.4.5 South Korea
  • 9.4.6 China Taiwan
  • 9.4.7 Southeast Asia
  • 9.4.8 India
  • 9.4.9 Australia

10 Middle East, Africa, and Latin America

• 10.1 Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size (2018-2029)
• 10.2 Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size by Type
  • 10.2.1 Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size by Type (2018-2023)
  • 10.2.2 Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size by Type (2024-2029)
  • 10.2.3 Middle East, Africa, and Latin America AI in Respiratory Diseases Market Share by Type (2018-2029)
• 10.3 Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size by Application
  • 10.3.1 Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size by Application (2018-2023)
  • 10.3.2 Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size by Application (2024-2029)
  • 10.3.3 Middle East, Africa, and Latin America AI in Respiratory Diseases Market Share by Application (2018-2029)
• 10.4 Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size by Country
  • 10.4.1 Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size by Country: 2018 VS 2022 VS 2029
  • 10.4.2 Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size by Country (2018-2023)
  • 10.4.3 Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size by Country (2024-2029)
  • 10.4.4 Brazil
  • 10.4.5 Mexico
  • 10.4.6 Turkey
  • 10.4.7 Saudi Arabia
  • 10.4.8 Israel
  • 10.4.9 GCC Countries

11 Key Players Profiles

• 11.1 ArtiQ
  • 11.1.1 ArtiQ Company Details
  • 11.1.2 ArtiQ Business Overview
  • 11.1.3 ArtiQ AI in Respiratory Diseases Introduction
  • 11.1.4 ArtiQ Revenue in AI in Respiratory Diseases Business (2018-2023)
  • 11.1.5 ArtiQ Recent Developments
• 11.2 Philips Healthcare
  • 11.2.1 Philips Healthcare Company Details
  • 11.2.2 Philips Healthcare Business Overview
  • 11.2.3 Philips Healthcare AI in Respiratory Diseases Introduction
  • 11.2.4 Philips Healthcare Revenue in AI in Respiratory Diseases Business (2018-2023)
  • 11.2.5 Philips Healthcare Recent Developments
• 11.3 GE Healthcare
  • 11.3.1 GE Healthcare Company Details
  • 11.3.2 GE Healthcare Business Overview
  • 11.3.3 GE Healthcare AI in Respiratory Diseases Introduction
  • 11.3.4 GE Healthcare Revenue in AI in Respiratory Diseases Business (2018-2023)
  • 11.3.5 GE Healthcare Recent Developments
• 11.4 Siemens Healthineers
  • 11.4.1 Siemens Healthineers Company Details
  • 11.4.2 Siemens Healthineers Business Overview
  • 11.4.3 Siemens Healthineers AI in Respiratory Diseases Introduction
  • 11.4.4 Siemens Healthineers Revenue in AI in Respiratory Diseases Business (2018-2023)
  • 11.4.5 Siemens Healthineers Recent Developments
• 11.5 Swaasa AI
  • 11.5.1 Swaasa AI Company Details
  • 11.5.2 Swaasa AI Business Overview
  • 11.5.3 Swaasa AI AI in Respiratory Diseases Introduction
  • 11.5.4 Swaasa AI Revenue in AI in Respiratory Diseases Business (2018-2023)
  • 11.5.5 Swaasa AI Recent Developments
• 11.6 THIRONA
  • 11.6.1 THIRONA Company Details
  • 11.6.2 THIRONA Business Overview
  • 11.6.3 THIRONA AI in Respiratory Diseases Introduction
  • 11.6.4 THIRONA Revenue in AI in Respiratory Diseases Business (2018-2023)
  • 11.6.5 THIRONA Recent Developments
• 11.7 DeepMind Health
  • 11.7.1 DeepMind Health Company Details
  • 11.7.2 DeepMind Health Business Overview
  • 11.7.3 DeepMind Health AI in Respiratory Diseases Introduction
  • 11.7.4 DeepMind Health Revenue in AI in Respiratory Diseases Business (2018-2023)
  • 11.7.5 DeepMind Health Recent Developments
• 11.8 Verily
  • 11.8.1 Verily Company Details
  • 11.8.2 Verily Business Overview
  • 11.8.3 Verily AI in Respiratory Diseases Introduction
  • 11.8.4 Verily Revenue in AI in Respiratory Diseases Business (2018-2023)
  • 11.8.5 Verily Recent Developments
• 11.9 VIDA Diagnostics Inc
  • 11.9.1 VIDA Diagnostics Inc Company Details
  • 11.9.2 VIDA Diagnostics Inc Business Overview
  • 11.9.3 VIDA Diagnostics Inc AI in Respiratory Diseases Introduction
  • 11.9.4 VIDA Diagnostics Inc Revenue in AI in Respiratory Diseases Business (2018-2023)
  • 11.9.5 VIDA Diagnostics Inc Recent Developments
• 11.10 Icometrix
  • 11.10.1 Icometrix Company Details
  • 11.10.2 Icometrix Business Overview
  • 11.10.3 Icometrix AI in Respiratory Diseases Introduction
  • 11.10.4 Icometrix Revenue in AI in Respiratory Diseases Business (2018-2023)
  • 11.10.5 Icometrix Recent Developments
• 11.11 Infervision
  • 11.11.1 Infervision Company Details
  • 11.11.2 Infervision Business Overview
  • 11.11.3 Infervision AI in Respiratory Diseases Introduction
  • 11.11.4 Infervision Revenue in AI in Respiratory Diseases Business (2018-2023)
  • 11.11.5 Infervision Recent Developments
• 11.12 PneumoWave
  • 11.12.1 PneumoWave Company Details
  • 11.12.2 PneumoWave Business Overview
  • 11.12.3 PneumoWave AI in Respiratory Diseases Introduction
  • 11.12.4 PneumoWave Revenue in AI in Respiratory Diseases Business (2018-2023)
  • 11.12.5 PneumoWave Recent Developments
• 11.13 Respiray
  • 11.13.1 Respiray Company Details
  • 11.13.2 Respiray Business Overview
  • 11.13.3 Respiray AI in Respiratory Diseases Introduction
  • 11.13.4 Respiray Revenue in AI in Respiratory Diseases Business (2018-2023)
  • 11.13.5 Respiray Recent Developments
• 11.14 Dectrocel Healthcare
  • 11.14.1 Dectrocel Healthcare Company Details
  • 11.14.2 Dectrocel Healthcare Business Overview
  • 11.14.3 Dectrocel Healthcare AI in Respiratory Diseases Introduction
  • 11.14.4 Dectrocel Healthcare Revenue in AI in Respiratory Diseases Business (2018-2023)
  • 11.14.5 Dectrocel Healthcare Recent Developments
• 11.15 Zynnon
  • 11.15.1 Zynnon Company Details
  • 11.15.2 Zynnon Business Overview
  • 11.15.3 Zynnon AI in Respiratory Diseases Introduction
  • 11.15.4 Zynnon Revenue in AI in Respiratory Diseases Business (2018-2023)
  • 11.15.5 Zynnon Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer
• 13.3 Author Details

List of Tables

• Table 1. Global AI in Respiratory Diseases Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
• Table 2. Key Players of Pulmonary Infection
• Table 3. Key Players of MRI
• Table 4. Key Players of CT Scan
• Table 5. Global AI in Respiratory Diseases Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
• Table 6. Global AI in Respiratory Diseases Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
• Table 7. Global AI in Respiratory Diseases Market Size by Region (2018-2023) & (US$ Million)
• Table 8. Global AI in Respiratory Diseases Market Share by Region (2018-2023)
• Table 9. Global AI in Respiratory Diseases Forecasted Market Size by Region (2024-2029) & (US$ Million)
• Table 10. Global AI in Respiratory Diseases Market Share by Region (2024-2029)
• Table 11. AI in Respiratory Diseases Market Trends
• Table 12. AI in Respiratory Diseases Market Drivers
• Table 13. AI in Respiratory Diseases Market Challenges
• Table 14. AI in Respiratory Diseases Market Restraints
• Table 15. Global AI in Respiratory Diseases Revenue by Players (2018-2023) & (US$ Million)
• Table 16. Global AI in Respiratory Diseases Revenue Share by Players (2018-2023)
• Table 17. Global Top AI in Respiratory Diseases by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI in Respiratory Diseases as of 2022)
• Table 18. Global AI in Respiratory Diseases Industry Ranking 2021 VS 2022 VS 2023
• Table 19. Global 5 Largest Players Market Share by AI in Respiratory Diseases Revenue (CR5 and HHI) & (2018-2023)
• Table 20. Global Key Players of AI in Respiratory Diseases, Headquarters and Area Served
• Table 21. Global Key Players of AI in Respiratory Diseases, Product and Application
• Table 22. Global Key Players of AI in Respiratory Diseases, Product and Application
• Table 23. Mergers & Acquisitions, Expansion Plans
• Table 24. Global AI in Respiratory Diseases Market Size by Type (2018-2023) & (US$ Million)
• Table 25. Global AI in Respiratory Diseases Revenue Market Share by Type (2018-2023)
• Table 26. Global AI in Respiratory Diseases Forecasted Market Size by Type (2024-2029) & (US$ Million)
• Table 27. Global AI in Respiratory Diseases Revenue Market Share by Type (2024-2029)
• Table 28. Global AI in Respiratory Diseases Market Size by Application (2018-2023) & (US$ Million)
• Table 29. Global AI in Respiratory Diseases Revenue Share by Application (2018-2023)
• Table 30. Global AI in Respiratory Diseases Forecasted Market Size by Application (2024-2029) & (US$ Million)
• Table 31. Global AI in Respiratory Diseases Revenue Share by Application (2024-2029)
• Table 32. North America AI in Respiratory Diseases Market Size by Type (2018-2023) & (US$ Million)
• Table 33. North America AI in Respiratory Diseases Market Size by Type (2024-2029) & (US$ Million)
• Table 34. North America AI in Respiratory Diseases Market Size by Application (2018-2023) & (US$ Million)
• Table 35. North America AI in Respiratory Diseases Market Size by Application (2024-2029) & (US$ Million)
• Table 36. North America AI in Respiratory Diseases Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
• Table 37. North America AI in Respiratory Diseases Market Size by Country (2018-2023) & (US$ Million)
• Table 38. North America AI in Respiratory Diseases Market Size by Country (2024-2029) & (US$ Million)
• Table 39. Europe AI in Respiratory Diseases Market Size by Type (2018-2023) & (US$ Million)
• Table 40. Europe AI in Respiratory Diseases Market Size by Type (2024-2029) & (US$ Million)
• Table 41. Europe AI in Respiratory Diseases Market Size by Application (2018-2023) & (US$ Million)
• Table 42. Europe AI in Respiratory Diseases Market Size by Application (2024-2029) & (US$ Million)
• Table 43. Europe AI in Respiratory Diseases Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
• Table 44. Europe AI in Respiratory Diseases Market Size by Country (2018-2023) & (US$ Million)
• Table 45. Europe AI in Respiratory Diseases Market Size by Country (2024-2029) & (US$ Million)
• Table 46. China AI in Respiratory Diseases Market Size by Type (2018-2023) & (US$ Million)
• Table 47. China AI in Respiratory Diseases Market Size by Type (2024-2029) & (US$ Million)
• Table 48. China AI in Respiratory Diseases Market Size by Application (2018-2023) & (US$ Million)
• Table 49. China AI in Respiratory Diseases Market Size by Application (2024-2029) & (US$ Million)
• Table 50. Asia AI in Respiratory Diseases Market Size by Type (2018-2023) & (US$ Million)
• Table 51. Asia AI in Respiratory Diseases Market Size by Type (2024-2029) & (US$ Million)
• Table 52. Asia AI in Respiratory Diseases Market Size by Application (2018-2023) & (US$ Million)
• Table 53. Asia AI in Respiratory Diseases Market Size by Application (2024-2029) & (US$ Million)
• Table 54. Asia AI in Respiratory Diseases Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
• Table 55. Asia AI in Respiratory Diseases Market Size by Region (2018-2023) & (US$ Million)
• Table 56. Asia AI in Respiratory Diseases Market Size by Region (2024-2029) & (US$ Million)
• Table 57. Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size by Type (2018-2023) & (US$ Million)
• Table 58. Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size by Type (2024-2029) & (US$ Million)
• Table 59. Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size by Application (2018-2023) & (US$ Million)
• Table 60. Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size by Application (2024-2029) & (US$ Million)
• Table 61. Middle East, Africa, and Latin America AI in Respiratory Diseases Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
• Table 62. Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size by Country (2018-2023) & (US$ Million)
• Table 63. Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size by Country (2024-2029) & (US$ Million)
• Table 64. ArtiQ Company Details
• Table 65. ArtiQ Business Overview
• Table 66. ArtiQ AI in Respiratory Diseases Product
• Table 67. ArtiQ Revenue in AI in Respiratory Diseases Business (2018-2023) & (US$ Million)
• Table 68. ArtiQ Recent Developments
• Table 69. Philips Healthcare Company Details
• Table 70. Philips Healthcare Business Overview
• Table 71. Philips Healthcare AI in Respiratory Diseases Product
• Table 72. Philips Healthcare Revenue in AI in Respiratory Diseases Business (2018-2023) & (US$ Million)
• Table 73. Philips Healthcare Recent Developments
• Table 74. GE Healthcare Company Details
• Table 75. GE Healthcare Business Overview
• Table 76. GE Healthcare AI in Respiratory Diseases Product
• Table 77. GE Healthcare Revenue in AI in Respiratory Diseases Business (2018-2023) & (US$ Million)
• Table 78. GE Healthcare Recent Developments
• Table 79. Siemens Healthineers Company Details
• Table 80. Siemens Healthineers Business Overview
• Table 81. Siemens Healthineers AI in Respiratory Diseases Product
• Table 82. Siemens Healthineers Revenue in AI in Respiratory Diseases Business (2018-2023) & (US$ Million)
• Table 83. Siemens Healthineers Recent Developments
• Table 84. Swaasa AI Company Details
• Table 85. Swaasa AI Business Overview
• Table 86. Swaasa AI AI in Respiratory Diseases Product
• Table 87. Swaasa AI Revenue in AI in Respiratory Diseases Business (2018-2023) & (US$ Million)
• Table 88. Swaasa AI Recent Developments
• Table 89. THIRONA Company Details
• Table 90. THIRONA Business Overview
• Table 91. THIRONA AI in Respiratory Diseases Product
• Table 92. THIRONA Revenue in AI in Respiratory Diseases Business (2018-2023) & (US$ Million)
• Table 93. THIRONA Recent Developments
• Table 94. DeepMind Health Company Details
• Table 95. DeepMind Health Business Overview
• Table 96. DeepMind Health AI in Respiratory Diseases Product
• Table 97. DeepMind Health Revenue in AI in Respiratory Diseases Business (2018-2023) & (US$ Million)
• Table 98. DeepMind Health Recent Developments
• Table 99. Verily Company Details
• Table 100. Verily Business Overview
• Table 101. Verily AI in Respiratory Diseases Product
• Table 102. Verily Revenue in AI in Respiratory Diseases Business (2018-2023) & (US$ Million)
• Table 103. Verily Recent Developments
• Table 104. VIDA Diagnostics Inc Company Details
• Table 105. VIDA Diagnostics Inc Business Overview
• Table 106. VIDA Diagnostics Inc AI in Respiratory Diseases Product
• Table 107. VIDA Diagnostics Inc Revenue in AI in Respiratory Diseases Business (2018-2023) & (US$ Million)
• Table 108. VIDA Diagnostics Inc Recent Developments
• Table 109. Icometrix Company Details
• Table 110. Icometrix Business Overview
• Table 111. Icometrix AI in Respiratory Diseases Product
• Table 112. Icometrix Revenue in AI in Respiratory Diseases Business (2018-2023) & (US$ Million)
• Table 113. Icometrix Recent Developments
• Table 114. Infervision Company Details
• Table 115. Infervision Business Overview
• Table 116. Infervision AI in Respiratory Diseases Product
• Table 117. Infervision Revenue in AI in Respiratory Diseases Business (2018-2023) & (US$ Million)
• Table 118. Infervision Recent Developments
• Table 119. PneumoWave Company Details
• Table 120. PneumoWave Business Overview
• Table 121. PneumoWave AI in Respiratory Diseases Product
• Table 122. PneumoWave Revenue in AI in Respiratory Diseases Business (2018-2023) & (US$ Million)
• Table 123. PneumoWave Recent Developments
• Table 124. Respiray Company Details
• Table 125. Respiray Business Overview
• Table 126. Respiray AI in Respiratory Diseases Product
• Table 127. Respiray Revenue in AI in Respiratory Diseases Business (2018-2023) & (US$ Million)
• Table 128. Respiray Recent Developments
• Table 129. Dectrocel Healthcare Company Details
• Table 130. Dectrocel Healthcare Business Overview
• Table 131. Dectrocel Healthcare AI in Respiratory Diseases Product
• Table 132. Dectrocel Healthcare Revenue in AI in Respiratory Diseases Business (2018-2023) & (US$ Million)
• Table 133. Dectrocel Healthcare Recent Developments
• Table 134. Zynnon Company Details
• Table 135. Zynnon Business Overview
• Table 136. Zynnon AI in Respiratory Diseases Product
• Table 137. Zynnon Revenue in AI in Respiratory Diseases Business (2018-2023) & (US$ Million)
• Table 138. Zynnon Recent Developments
• Table 139. Research Programs/Design for This Report
• Table 140. Key Data Information from Secondary Sources
• Table 141. Key Data Information from Primary Sources

List of Figures

• Figure 1. Global AI in Respiratory Diseases Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
• Figure 2. Global AI in Respiratory Diseases Market Share by Type: 2022 VS 2029
• Figure 3. Pulmonary Infection Features
• Figure 4. MRI Features
• Figure 5. CT Scan Features
• Figure 6. Global AI in Respiratory Diseases Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
• Figure 7. Global AI in Respiratory Diseases Market Share by Application: 2022 VS 2029
• Figure 8. Hospital Case Studies
• Figure 9. Diagnostic Centers Case Studies
• Figure 10. Ambulatory Surgical Centers Case Studies
• Figure 11. Others Case Studies
• Figure 12. AI in Respiratory Diseases Report Years Considered
• Figure 13. Global AI in Respiratory Diseases Market Size (US$ Million), Year-over-Year: 2018-2029
• Figure 14. Global AI in Respiratory Diseases Market Size, (US$ Million), 2018 VS 2022 VS 2029
• Figure 15. Global AI in Respiratory Diseases Market Share by Region: 2022 VS 2029
• Figure 16. Global AI in Respiratory Diseases Market Share by Players in 2022
• Figure 17. Global Top AI in Respiratory Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI in Respiratory Diseases as of 2022)
• Figure 18. The Top 10 and 5 Players Market Share by AI in Respiratory Diseases Revenue in 2022
• Figure 19. North America AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 20. North America AI in Respiratory Diseases Market Share by Type (2018-2029)
• Figure 21. North America AI in Respiratory Diseases Market Share by Application (2018-2029)
• Figure 22. North America AI in Respiratory Diseases Market Share by Country (2018-2029)
• Figure 23. United States AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 24. Canada AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 25. Europe AI in Respiratory Diseases Market Size YoY (2018-2029) & (US$ Million)
• Figure 26. Europe AI in Respiratory Diseases Market Share by Type (2018-2029)
• Figure 27. Europe AI in Respiratory Diseases Market Share by Application (2018-2029)
• Figure 28. Europe AI in Respiratory Diseases Market Share by Country (2018-2029)
• Figure 29. Germany AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 30. France AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 31. U.K. AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 32. Italy AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 33. Russia AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 34. Nordic Countries AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 35. China AI in Respiratory Diseases Market Size YoY (2018-2029) & (US$ Million)
• Figure 36. China AI in Respiratory Diseases Market Share by Type (2018-2029)
• Figure 37. China AI in Respiratory Diseases Market Share by Application (2018-2029)
• Figure 38. Asia AI in Respiratory Diseases Market Size YoY (2018-2029) & (US$ Million)
• Figure 39. Asia AI in Respiratory Diseases Market Share by Type (2018-2029)
• Figure 40. Asia AI in Respiratory Diseases Market Share by Application (2018-2029)
• Figure 41. Asia AI in Respiratory Diseases Market Share by Region (2018-2029)
• Figure 42. Japan AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 43. South Korea AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 44. China Taiwan AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 45. Southeast Asia AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 46. India AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 47. Australia AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 48. Middle East, Africa, and Latin America AI in Respiratory Diseases Market Size YoY (2018-2029) & (US$ Million)
• Figure 49. Middle East, Africa, and Latin America AI in Respiratory Diseases Market Share by Type (2018-2029)
• Figure 50. Middle East, Africa, and Latin America AI in Respiratory Diseases Market Share by Application (2018-2029)
• Figure 51. Middle East, Africa, and Latin America AI in Respiratory Diseases Market Share by Country (2018-2029)
• Figure 52. Brazil AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 53. Mexico AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 54. Turkey AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 55. Saudi Arabia AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 56. Israel AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 57. GCC Countries AI in Respiratory Diseases Market Size YoY Growth (2018-2029) & (US$ Million)
• Figure 58. ArtiQ Revenue Growth Rate in AI in Respiratory Diseases Business (2018-2023)
• Figure 59. Philips Healthcare Revenue Growth Rate in AI in Respiratory Diseases Business (2018-2023)
• Figure 60. GE Healthcare Revenue Growth Rate in AI in Respiratory Diseases Business (2018-2023)
• Figure 61. Siemens Healthineers Revenue Growth Rate in AI in Respiratory Diseases Business (2018-2023)
• Figure 62. Swaasa AI Revenue Growth Rate in AI in Respiratory Diseases Business (2018-2023)
• Figure 63. THIRONA Revenue Growth Rate in AI in Respiratory Diseases Business (2018-2023)
• Figure 64. DeepMind Health Revenue Growth Rate in AI in Respiratory Diseases Business (2018-2023)
• Figure 65. Verily Revenue Growth Rate in AI in Respiratory Diseases Business (2018-2023)
• Figure 66. VIDA Diagnostics Inc Revenue Growth Rate in AI in Respiratory Diseases Business (2018-2023)
• Figure 67. Icometrix Revenue Growth Rate in AI in Respiratory Diseases Business (2018-2023)
• Figure 68. Infervision Revenue Growth Rate in AI in Respiratory Diseases Business (2018-2023)
• Figure 69. PneumoWave Revenue Growth Rate in AI in Respiratory Diseases Business (2018-2023)
• Figure 70. Respiray Revenue Growth Rate in AI in Respiratory Diseases Business (2018-2023)
• Figure 71. Dectrocel Healthcare Revenue Growth Rate in AI in Respiratory Diseases Business (2018-2023)
• Figure 72. Zynnon Revenue Growth Rate in AI in Respiratory Diseases Business (2018-2023)
• Figure 73. Bottom-up and Top-down Approaches for This Report
• Figure 74. Data Triangulation
• Figure 75. Key Executives Interviewed